Finn Guo: Access and Affordability Challenges for Von Willebrand Disease in China
Finn Guo, Director of Information Research at Illness Challenge Foundation, shared on LinkedIn:
”Von Willebrand disease is frequently misdiagnosed or overlooked.
Unlike Hemophilia, patients with VWD often lack the carrier protein that stabilises and transports clotting factor, rather than the clotting factor itself.
As a result, treatment approaches designed for hemophilia are not always clinically appropriate for VWD.
In China, the only approved therapy for VWD has not yet been included in the National Reimbursement Drug List (NRDL).
With annual treatment costs reaching tens of thousands of USDs, many patients remain unable to afford sustained care.
At this stage, one of the few mechanisms that can partially alleviate the financial burden is Inclusive Commercial Health Insurance (ICHI).
This creates a practical space for evidence-based advocacy: patient communities can work with industry and other stakeholders to support the inclusion of appropriate therapies within ICHI schemes.
Three priorities are particularly important:
- Clarifying the disease image — differentiating VWD from hemophilia in public and policy understanding.
- Articulating specific clinical needs — recognising that hemophilia treatment models may not apply.
- Communicating the real-world affordability gap — when annual costs reach tens of thousands of dollars, access becomes structurally constrained.
Advancing equity in rare bleeding disorders requires accurate diagnosis, appropriate therapy, and payment pathways that reflect clinical reality.”

Stay updated with Hemostasis Today.
-
Nov 18, 2026, 20:58Uma Vaidyanathan: When Hemoglobin Does Not Respond to Iron Therapy, Look Beyond Iron Deficiency
-
Nov 18, 2026, 20:57Jamil Rafiq: 5 Ways to Prevent Sample Haemolysis
-
Nov 18, 2026, 20:55Nasir Jamal: Plasmapheresis – Key Concepts at a Glance
-
Nov 18, 2026, 20:55Tarık Seller: Pulmonary Embolism – When a Blood Clot Becomes a Life-Threatening Emergency
-
Nov 18, 2026, 20:53Sandya Arunachalam: Bringing the Profession Together at the Haemostasis and Thrombosis Workshop
-
Nov 18, 2026, 15:11Vansh Yaduvanshi: Why Compatible Blood Groups Do Not Always Mean Compatible Blood
-
Nov 18, 2026, 14:49Estetrol-Based Contraception in PCOS and Its Effects on Coagulation – RPTH Journal
-
Nov 18, 2026, 14:41Factor V Deficiency: Diagnostic Challenges and the Role of Combined Factor V and VIII Deficiency
-
Nov 18, 2026, 14:29Maxime Dely: When Patient Encounters Become Life Lessons